(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SCIANDA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SCIANDA

ST13

US500000086042807

Class

5

Filing

86042807

Registration

5211478

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

05/31/2026

Trademark type

Combined

Nice classes

5

Filing date

08/20/2013

Registration date

05/30/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/22/2023

Last transaction

05/31/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

Drawing code

5

Owner type

03

Owner location

Shan-Hua, Tainan, TW

Examiner

BULLOFF, TOBY ELLEN

Law office

N10

Current location

TMO LAW OFFICE 119

Mark description

The mark consists of the invented wording "SciAnda".

Holders and representatives

Holders

ScinoPharm Taiwan, Ltd.
ScinoPharm Taiwan, Ltd.

Representatives

Daniel Lano IpHorgan Ltd.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Active pharmaceutical ingredients sold as integral components of pharmaceutical preparations for treating cancerautoimmune diseasesinfectious diseasesinflammatory diseasesgenetic diseasesrespiratory diseasesmental diseasesophthalmic diseasesdigestive diseasesendocrine diseasesdiseases of muscle-skeletal systemmetabolic disorder diseasesdiseases of central nervous systemcardiovascular diseases; medicines for use in humans for treating cancerautoimmune diseasesinfectious diseasesinflammatory diseasesgenetic diseasesrespiratory diseasesmental diseasesophthalmic diseasesdigestive diseasesendocrine diseasesdiseases of muscle-skeletal systemmetabolic disorder diseasesdiseases of central nervous systemcardiovascular diseases

Publications

History of USPTO decisions and trademark events.

52 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/30/2026

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/22/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/22/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/22/2023

E815

TEAS SECTION 8 & 15 RECEIVED

05/25/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/30/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/30/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/14/2017

PUBO

PUBLISHED FOR OPPOSITION

03/14/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/22/2017

IUCN

NOTICE OF ALLOWANCE CANCELLED

02/03/2017

ATRQ

ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED

02/03/2017

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

02/03/2017

APET

ASSIGNED TO PETITION STAFF

01/27/2017

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

12/16/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/09/2016

EX5G

SOU EXTENSION 5 GRANTED

12/08/2016

EXT5

SOU EXTENSION 5 FILED

11/21/2016

EEXT

SOU TEAS EXTENSION RECEIVED

11/21/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/15/2016

EX4G

SOU EXTENSION 4 GRANTED

06/14/2016

EXT4

SOU EXTENSION 4 FILED

05/31/2016

EEXT

SOU TEAS EXTENSION RECEIVED

05/31/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/03/2015

EX3G

SOU EXTENSION 3 GRANTED

12/02/2015

EXT3

SOU EXTENSION 3 FILED

11/24/2015

EEXT

SOU TEAS EXTENSION RECEIVED

11/24/2015

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/19/2015

EX2G

SOU EXTENSION 2 GRANTED

05/18/2015

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/15/2015

EXT2

SOU EXTENSION 2 FILED

04/14/2015

EEXT

SOU TEAS EXTENSION RECEIVED

04/14/2015

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/04/2014

EX1G

SOU EXTENSION 1 GRANTED

12/02/2014

EXT1

SOU EXTENSION 1 FILED

12/02/2014

EEXT

SOU TEAS EXTENSION RECEIVED

12/02/2014

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/17/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/22/2014

PUBO

PUBLISHED FOR OPPOSITION

04/22/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/02/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/15/2014

ALIE

ASSIGNED TO LIE

03/12/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/24/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/21/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/20/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/20/2014

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/05/2013

GNRT

NON-FINAL ACTION E-MAILED

12/05/2013

CNRT

NON-FINAL ACTION WRITTEN

12/05/2013

DOCK

ASSIGNED TO EXAMINER

12/05/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/28/2013

NWAP

NEW APPLICATION ENTERED

08/23/2013

Continuous trademark protection

Get notified about every new filing that threatens SCIANDA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.